Samantha Olson, MPH, highlights how maternal vaccination protects infants from influenza.
Following positive results from a study published in JAMA Pediatrics, study investigator Samantha Olson, MPH, epidemiologist, Influenza Division, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, joined Contemporary Pediatrics to explain the importance of maternal influenza vaccination and its association with infant protection.
"We know that infants have a high risk of hospitalization for influenza and other serious influenza complications," Olson said. "Infants are not eligible to receive that flu vaccine until they're 6 months of age, so really, mothers getting vaccinated during pregnancy provide that protection for both themselves and their infants until they're eligible for vaccination."
Olson also reminds providers that influenza is still in season.
"We expect flu cases to remain elevated over the next couple of weeks," said Olson. "So it's not too late to get vaccinated for pregnant persons, for those considering becoming pregnant, or those who are postpartum. It's not too late to receive that flu vaccine to provide protection to both themselves and their babies."
"Also to the pediatricians, children 6 months and older are eligible for flu vaccination, so it is not too late for them to get vaccinated."
In Olson and colleagues' study published in JAMA Pediatrics, results revealed that maternal vaccination was associated with a reduction in influenza-associated hospitalizations and ED visits in infants, providing protection until vaccine eligibility for infants at 6 months of age.
This is the second video interview with Samantha Olson, MPH. Click here to view the first episode.
This interview was initially published by our sister publication Contemporary Pediatrics.
Reference:
Sahni LC, Olson SM, Halasa NB, et al. Maternal vaccine effectiveness against influenza-associated hospitalizations and emergency department visits in infants. JAMA Pediatr. 2024;178(2):176–184. doi:10.1001/jamapediatrics.2023.5639
Cesarean delivery reduces mortality risk in preterm breech births
December 2nd 2024In a recent study, infants born very preterm or extremely preterm had reduced odds of mortality when cesarean delivery was chosen as the mode of delivery, without a notable increase in any morbidity risk.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Maternal sFLT1 and EDN1 linked to late-onset preeclampsia
November 25th 2024A new study highlights the association of maternal soluble Fms-like tyrosine kinase 1 and endothelin 1 with preeclampsia severity, offering insights into the pathogenesis of early- and late-onset forms of the condition.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More